Shalini Sharp, CFO & Executive Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 13,000 shares at $70.17 ($912K) on 2018-05-30, disclosed to the SEC on 2018-05-30.
Seasonal sale ($912k) by CFO & Executive Vice President — this insider has traded RARE in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| RARE | SELL | 2020-08-19 | $2.5M | — | Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |